SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 3)*
International Flavors & Fragrances Inc.
-----------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock $.12-1/2 par value
-----------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
459506 10 1
---------------------------------------
(CUSIP NUMBER)
George Rowe, Jr., One Rockefeller Plaza,
New York, N.Y. 10020 (Tel. 212-586-0700)
-----------------------------------------------------------------------
(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON
AUTHORIZED TO RECEIVE NOTICES AND COMMUNICATIONS)
DECEMBER 9, 2002
-----------------------------------------
(DATE OF EVENT WHICH REQUIRES FILING
OF THIS STATEMENT)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule l3d-l(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the statement / /. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule l3d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule l3d-l(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 5 Pages
---
CUSIP No. 459506 10 1 13D PAGE 2 OF 5 PAGES
-------------- --- ---
1
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Henry P. van Ameringen
-----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /x/
-----------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------
4 SOURCE OF FUNDS*
NOT APPLICABLE
-----------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED / /
PURSUANT TO ITEMS 2(d)or 2(e)
-----------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-----------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 2,570,011
------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
4,536,239
EACH ------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON 2,570,011
------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
4,536,239
-----------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,106,250
-----------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES / /
CERTAIN SHARES*
-----------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.5%
-----------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
-----------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13 D
Under the Securities Exchange Act of 1934
Check the following box if a fee is being paid with this
statement. / /
Item 1 Security and Issurer
--------------------
Common Stock $.12-1/2 par value
International Flavors & Fragrances Inc. (IFF)
521 West 57th Street
New York, New York 10019
Item 2 Identity and Background
-----------------------
(a) Name of Person Filing:
---------------------
Henry P. van Ameringen
(b) Residence or Business Address
-----------------------------
509 Madison Avenue
New York, New York 10022
(c) Present principal occupation or employment and the name,
principal business and address of any corporation or other
organization in which such employment is conducted;
Retired as an executive of IFF; President and Treasurer and a
director, van Ameringen Foundation at the address in 2(b)
(d) Whether or not, during the last five years, such person has
been convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors) and, if so, give the dates,
nature of conviction, name and location of court, any penalty
imposed or other disposition of the case;
No
(e) Whether or not, during the last five years, such person
was a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a
result of such proceeding was or is subject to a
judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding
any violation with respect to such laws; and, if so,
identify and describe such proceedings and summarize
the terms of such judgment, decree or final order, and
No
Page 3 of 5 Pages
Item 2 (f) Citizenship:
-----------
U.S.A.
Item 3 Source & Amount of Funds or Other Consideration
-----------------------------------------------
See Item 5(c) below.
Item 4 Purpose of Transaction
----------------------
See Item 5(c) below.
Item 5 Interest in Securities of the Issuer
------------------------------------
(a) Amount Beneficially Owned
7,106,250
Percent of Class
7.5%
(b) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 2,570,011
(ii) shared power to vote or to direct the vote:
4,536,239
(iii) sole power to dispose or to direct the disposition
of: 2,570,011
(iv) shared power to dispose or to direct the
disposition of: 4,536,239
(c) Describe any transactions in the class of securities reported
on that were effected during the past sixty days or since the
most recent filing on Schedule 13D (Section 240.13d-191),
whichever is less, by the persons named in response to
paragraph (a).
From November 6, 2002 to November 22, 2002, 438,000 shares were
sold on behalf of three trusts, of which the undersigned
is a co-trustee. In addition, from December 9, 2002 to
December 11, 2002, the van Ameringen Foundation, of which the
undersigned is a director and officer, sold 100,000 shares.
(d) If any other person is known to have the right to
receive or the power to direct the receipt of dividends
from, or the proceeds from the sale of, such
securities, a statement to that effect should be
included in response to this item and, if such interest
relates to more than five percent of the class, such
person should be identified. A listing of the
shareholders of an investment company registered under
the Investment Company Act of 1940 or the beneficiaries
of an employee benefit plan, pension fund or endowment
fund is not required.
Persons other than the undersigned have the right to receive
dividends from, or the proceeds from the sale of, certain of
the securities listed in Item 5 (a) and (b).
Page 4 of 5 Pages
Item 6 Contracts, Arrangements, Understandings
---------------------------------------
Or Relationships With Respect To
--------------------------------
Securities Of The Issuer
------------------------
None
Item 7 Material To Be Filed as Exhibits
--------------------------------
None
Signature
After reasonable inquiry and the best of my knowledge and belief, I certify
that the information set forth in the statement is true, complete and correct.
December 18, 2002
------------------------------
Date
HENRY P. VAN AMERINGEN
------------------------------
Signature
Henry P. van Ameringen
------------------------------
Name/Title
Hpv A13D
Page 5 of 5 Pages